Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3302205 | Gastrointestinal Endoscopy | 2015 | 11 Pages |
Abstract
In this large series of patients undergoing stent placement for malignant GOO in North America, we observed no difference in post-stent placement survival despite better overall survival in patients with nonpancreatic cancer. GOO is a marker for poor survival in malignancy, regardless of the type. Chemotherapy and the absence of distant metastasis were associated with better post-stent placement survival in both groups.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Stephen Y. MBBS, BSc, FRACP, Alicia MBA, Margaret PhD, Andrew MD, Shayan MD, Michael MD, Seng-Ian MD, Michael MD, Vincent MD, Scott MD, Richard A. MD,